Atıf İçin Kopyala
TÖRÜNER M., BAŞARANOĞLU M., ATUĞ Ö., Senturk O., Akyuz F., Cekic C., ...Daha Fazla
TURKISH JOURNAL OF GASTROENTEROLOGY, cilt.33, sa.5, ss.406-413, 2022 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
33
Sayı:
5
-
Basım Tarihi:
2022
-
Doi Numarası:
10.5152/tjg.2022.21868
-
Dergi Adı:
TURKISH JOURNAL OF GASTROENTEROLOGY
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus, CAB Abstracts, EMBASE, MEDLINE, TR DİZİN (ULAKBİM)
-
Sayfa Sayıları:
ss.406-413
-
Anahtar Kelimeler:
Anti-TNF, Crohn's disease, quality of life, work productivity, ACTIVITY IMPAIRMENT QUESTIONNAIRE, INFLAMMATORY-BOWEL-DISEASE, CERTOLIZUMAB PEGOL, MAINTENANCE, ADALIMUMAB, TRIAL, INFLIXIMAB, REMISSION, MODERATE, OUTCOMES
-
Dokuz Eylül Üniversitesi Adresli:
Evet
Özet
Background: Patients with Crohn's disease experience major deterioration in work productivity and quality of life. We aimed to provide the long-term effects of anti-tumor necrosis factor agents on work productivity and activity impairment and quality of life in patients with Crohn's disease using the Inflammatory Bowel Disease Questionnaire and the Short-Form Health Survey-36.